Antharis Therapeutics, Inc. logo

Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.

18 employees · est. 2020 · San Diego, United States

VS
DAAN Biotherapeutics logo

DAAN Biotherapeutics

Innovative treatments for cancer: empowering patients with advanced research in cell therapies, antibodies, and small molecule inhibitors.

est. 2020

Side-by-Side Comparison

Antharis Therapeutics, Inc. DAAN Biotherapeutics
Founded
2020 2020
Headquarters
San Diego, United States Not tracked yet
Employees
18 Not tracked yet
Industry
Biopharma, Biotechnology, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Not tracked yet Seed
Total Funding
Not tracked yet $5.00B
Funding Rounds
Not tracked yet 1
Services
Developing Transformative Medicines, Therapies Harnessing the Immune System, Cutting-edge Biomedical Research, Therapeutically-relevant Antibody Development Not tracked yet
Target Customers
Healthcare Professionals, Patients with Unmet Medical Needs, Cancer Patients, Medical Institutions, Biotech and Pharmaceutical Partners Not tracked yet
Taxonomy
Biopharmaceutical, Cancer Treatment, Monoclonal Antibodies, Antibody-drug Conjugates, Oncology, Therapeutic Antibodies, Inflammatory Diseases, Innovative Therapies, Biotech Acquisitions, Clinical Trials, Transformational Therapies, Unmet Medical Needs, Pioneering Research, Solid Tumor Therapy, Bispecific Antibodies Cancer Treatment, Cell Therapies, Antibodies, Small Molecule Inhibitors, Novel Treatments
Website
antharistherapeutics.com daanbiotpx.com
Antharis Therapeutics, Inc. logo

About Antharis Therapeutics, Inc.

Antharis Therapeutics, Inc., founded in 2020 by Dr. Raphael R Pinaud, is a multinational biopharmaceutical company headquartered in the United States. Specializing in cancer and inflammatory disease treatments, it employs cutting-edge science to create next-generation monoclonal antibodies and antib...

DAAN Biotherapeutics logo

About DAAN Biotherapeutics

DAAN Biotherapeutics is a biotechnology startup founded in 2020, dedicated to developing innovative treatments for cancer. Their focus lies in empowering patients with advanced research in cell therapies, antibodies, and small molecule inhibitors. The company has recently received a KRW5.00B Seed Ro...

We will tell you when either one moves

BounceWatch watches Antharis Therapeutics, Inc. and DAAN Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Antharis Therapeutics,... and DAAN Biotherapeutics — by email.

Frequently Asked Questions

Antharis Therapeutics, Inc. — Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.. DAAN Biotherapeutics — Innovative treatments for cancer: empowering patients with advanced research in cell therapies, antibodies, and small molecule inhibitors.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Antharis Therapeutics, Inc. has raised undisclosed funding while DAAN Biotherapeutics has raised $5.00B.
Antharis Therapeutics, Inc. and DAAN Biotherapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Antharis Therapeutics, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Antharis Therapeutics, Inc. on 27 Nov 2025, and DAAN Biotherapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy